Gene · 1806
Papers4,420
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
801 to 820 of 4,420
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A druggable addiction to de novo pyrimidine biosynthesis in diffuse midline glioma. | Cancer Cell | 2022 | 35985342 | PubTator, text mining | PubMed |
| Uncovering the roles of dihydropyrimidine dehydrogenase in fatty-acid induced steatosis using human cellular models. | Sci Rep | 2022 | 35982095 | PubTator, text mining | PubMed |
| Molecular Quantity Variations in Human-Mandibular-Bone Osteoid. | Calcif Tissue Int | 2022 | 35978052 | PubTator, text mining | PubMed |
| A paradigm shift in pharmacogenomics: From candidate polymorphisms to comprehensive sequencing. | Basic Clin Pharmacol Toxicol | 2022 | 35971800 | PubTator, text mining | PubMed |
| Rechallenging Fluoropyrimidine-Induced Cardiotoxicity and Neurotoxicity: A Report of Two Cases. | Cureus | 2022 | 35971344 | PubTator, text mining | PubMed |
| Obesity reduced survival with 5-fluorouracil and did not protect against chemotherapy-induced cachexia or immune cell cytotoxicity in mice. | Cancer Biol Ther | 2022 | 35968771 | PubTator, text mining | PubMed |
| Development of an extensive workflow for comprehensive clinical pharmacogenomic profiling: lessons from a pilot study on 100 whole exome sequencing data. | Pharmacogenomics J | 2022 | 35963939 | PubTator, text mining | PubMed |
| Renal impairment and DPD testing: Watch out for false-positive results! | Br J Clin Pharmacol | 2022 | 35939355 | PubTator, text mining | PubMed |
| 5FU-loaded PCL/Chitosan/Fe3O4 Core-Shell Nanofibers Structure: An Approach to Multi-Mode Anticancer System. | Adv Pharm Bull | 2022 | 35935046 | PubTator, text mining | PubMed |
| Germline thymidylate synthase deficiency impacts nucleotide metabolism and causes dyskeratosis congenita. | Am J Hum Genet | 2022 | 35931051 | PubTator, text mining | PubMed |
| Survival and complications after neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy for esophageal squamous cell cancer: A meta-analysis. | PLoS One | 2022 | 35930539 | PubTator, text mining | PubMed |
| MALAT1-miRNAs network regulate thymidylate synthase and affect 5FU-based chemotherapy. | Mol Med | 2022 | 35922756 | PubTator, text mining | PubMed |
| Array genotyping as diagnostic approach in medical genetics. | Mol Genet Genomic Med | 2022 | 35912641 | PubTator, text mining | PubMed |
| Effects of polymorphisms in the MTHFR gene on 5-FU hematological toxicity and efficacy in Thai colorectal cancer patients. | Front Oncol | 2022 | 35912215 | PubTator, text mining | PubMed |
| Comparison of Traditional and Industrial Sausages Baranjski Kulen and Kulenova Seka Using Comprehensive Proteome, Peptidome and Metabolome Techniques. | Food Technol Biotechnol | 2022 | 35910277 | PubTator, text mining | PubMed |
| Frontier progress of the combination of modern medicine and traditional Chinese medicine in the treatment of hepatocellular carcinoma. | Chin Med | 2022 | 35907976 | PubTator, text mining | PubMed |
| Genome-wide CRISPR Screening Reveals Pyrimidine Metabolic Reprogramming in 5-FU Chronochemotherapy of Colorectal Cancer. | Front Oncol | 2022 | 35903686 | PubTator, text mining | PubMed |
| ClinPharmSeq: A targeted sequencing panel for clinical pharmacogenetics implementation. | PLoS One | 2022 | 35901010 | PubTator, text mining | PubMed |
| Canine Gastric Cancer: Current Treatment Approaches. | Vet Sci | 2022 | 35893776 | PubTator, text mining | PubMed |
| Molecular Biomarkers in Cancer. | Biomolecules | 2022 | 35892331 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1806/papers?page=41